CoChat

Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?

Surrey, Eric S · 2010 · Current Opinion in Obstetrics & Gynecology

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Purpose of review Endometriosis is a gynecologic disorder that can lead to debilitating chronic pelvic pain and infertility. Gonadotropin-releasing hormone agonists (GnRHa) have emerged as a primary medical therapy for patients with symptomatic disease, but secondary hypoestrogenic side effects may limit compliance. Add-back therapy is a means of surmounting this problem. Recent findings Progestins such as norethindrone acetate may be administered with or without addition of low doses of estrogens to safely and effectively extend GnRHa therapy while minimizing side effects. Recent studies have demonstrated that the use of add-back enhances compliance and duration of therapy. The initiation of an add-back should not be deferred given evidence demonstrating an increase in vasomotor symptoms and bone loss if not administered concomitantly. The subset of adolescents with endometriosis who require GnRHa therapy should be administered an add-back, but require careful monitoring of bone mineral density. Summary Implementation of an appropriately selected add-back will significantly reduce hypoestrogenic side effects, enhance compliance, and allow for prolongation of therapy without interfering with the efficacy of GnRHa in treating symptomatic endometriosis.

Overview

Integrity signals

Registry

Crossref · 10.1097/gco.0b013e32833b35a7

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Cited by

See all 71

Metadata

Authors
Surrey, E. S.
Affiliations
Colorado Center for Reproductive Medicine (US)
Corresponding author
Surrey, Eric S
Venue
Current Opinion in Obstetrics & Gynecology
Published
2010-08
Volume
22
Issue
4
Pages
283-288
ISSN
1040-872X (ISSN-L)
OpenAlex
W2036733694
Cited by
64
References
36
Citations by year
2026: 3 · 2025: 4 · 2023: 5 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 7 · 2017: 3 · 2016: 3 · 2015: 6 · 2014: 6 · 2013: 6 · 2012: 6
FWCI
0.72
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Obstetrics & Gynecology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
Keywords
endometriosis, GnRH agonist, add-back therapy, norethindrone acetate, progestins, low-dose estrogen, medication adherence, vasomotor symptoms, bone loss, bone mineral density, adolescents, infertility, chronic pelvic pain
MeSH terms
Adolescent, Adult, Endometriosis, Estrogens, Female, Humans, Gonadotropin-Releasing Hormone, Osteoporosis, Progestins, Hormone Replacement Therapy, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? https://app.cochat.ai/papers/10.1097/gco.0b013e32833b35a7
The paper
Surrey, E. S. (2010). Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? Current Opinion in Obstetrics & Gynecology. https://doi.org/10.1097/gco.0b013e32833b35a7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.